{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Gelli M"],"funding":["Agence Nationale de la Recherche","French National Cancer Institute","Inserm Transfert","Institut Gustave Roussy"],"pagination":["4418"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10648258"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["15(17)"],"pubmed_abstract":["<h4>Background</h4>Despite improvements in characterization of CRC heterogeneity, appropriate risk stratification tools are still lacking in clinical practice. This study aimed to elucidate the primary tumor transcriptomic signatures associated with distinct metastatic routes.<h4>Methods</h4>Primary tumor specimens obtained from CRC patients with either isolated LM (CRC-Liver) or PM (CRC-Peritoneum) were analyzed by transcriptomic mRNA sequencing, gene set enrichment analyses (GSEA) and immunohistochemistry. We further assessed the clinico-pathological associations and prognostic value of our signature in the COAD-TCGA independent cohort.<h4>Results</h4>We identified a significantly different distribution of Consensus Molecular Subtypes between CRC-Liver and CRC-peritoneum groups. A transc"],"journal":["Cancers"],"pubmed_title":["Primary Colorectal Tumor Displays Differential Genomic Expression Profiles Associated with Hepatic and Peritoneal Metastases."],"pmcid":["PMC10648258"],"funding_grant_id":["20CR046-00","ANR-20-CE13-0031-01","2020-1-PL BIO-04","Mars Bleu\" and sponsorship"],"pubmed_authors":["Gelli M","Desterke C","Jaulin F","Bani MA","Laurent-Puig P","Boige V","Ferte C","Dartigues P","Perkins G","Job B","Mathieu JRR","Cartry J","Ducreux M","Goere D"],"additional_accession":[]},"is_claimable":false,"name":"Primary Colorectal Tumor Displays Differential Genomic Expression Profiles Associated with Hepatic and Peritoneal Metastases.","description":"<h4>Background</h4>Despite improvements in characterization of CRC heterogeneity, appropriate risk stratification tools are still lacking in clinical practice. This study aimed to elucidate the primary tumor transcriptomic signatures associated with distinct metastatic routes.<h4>Methods</h4>Primary tumor specimens obtained from CRC patients with either isolated LM (CRC-Liver) or PM (CRC-Peritoneum) were analyzed by transcriptomic mRNA sequencing, gene set enrichment analyses (GSEA) and immunohistochemistry. We further assessed the clinico-pathological associations and prognostic value of our signature in the COAD-TCGA independent cohort.<h4>Results</h4>We identified a significantly different distribution of Consensus Molecular Subtypes between CRC-Liver and CRC-peritoneum groups. A transc","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Sep","modification":"2025-04-26T17:18:26.089Z","creation":"2025-04-06T15:30:43.805Z"},"accession":"S-EPMC10648258","cross_references":{"pubmed":["37686695"],"doi":["10.3390/cancers15174418"]}}